NewslettersCell Therapy News Feasibility and Preclinical Efficacy of CD7-Unedited CD7 CAR T-Cells for T-Cell Malignancies By Bob - September 12, 2022 0 207 Researchers showed fratricide of CD7 CAR T-cells could be fully prevented using ibrutinib and dasatinib, the pharmacologic inhibitors of key CAR/CD3ζ signaling kinases. [Molecular Therapy] AbstractGraphical Abstract